i want to make sure i am understanding what you are saying. so the mcb and the wcb both have been produced by eurofins and are back at pmcb facilities being tested for trials?
Step 1: They need a stable cell line to test. Kenny confessed the cell line was not homologous.
Note to Kenny: Your "confessions" of all the problems this scam has encountered constitutes material events. Where's that 8K Kenny?
and if everything went well. PMCB will file IND in Q1 2018
Step 2: The FDA would require safety tests on the xenogeneic cell line. GMP testing of manufacture methods. Toxicity testing, including viral infection. Proof that implantation in animal models does not cause portal hypertension and portal vein thrombosis. A problem which occurs more often in the portal veins of the pancreas. Does the CIAB encapsulated "new" cell line cause fibrous adhesions? How long do the cells inside CIAB remain viable? When no longer viable, how long does it take CIAB to degrade, and dissolve in the host animal.
Nooooo... the FDA isn't going to allow whatever tests were done on a potentially different genetic cell line in 1998 to be magically teleported to 2017. So who is going to do all this work for PMCB? Naturally they will publish the results in a scientific journal - don't hold your breath while waiting.
There's nothing coming in Q1, other than PR rehash. While Kenny ponders how to pump this scam next year, there are several pancreatic cancer clinical trials by other "real" biotechs which will report results in 2018. The most interesting one late 2018.
News 
Market Data 
Discover 
